More bottles Lipitor cholesterol-lowering and releasing a musty smell had been found, what the drug with the manufacturer, Pfizer, to expand its current upswing.
The recall relates to a new batch of 19,000 additional unlimited bottles of 40 mg Lipitor, which brings the total number of bottles from the shelves to 360,000.
In a statement, Pfizer attributed to the musty smell of a chemical called 2,4,6-tribromoanisole (TBA), in a bottle of Lipitor were what one of the largest consumer complaints.The FDA identified noted that the health effects of low have taken concentrations of TBA is minimal, especially gastrointestinal upset consumers, the products affected by the aromatic compound.
TBA is actually from another chemical, TED, as a preservative in wood shipping pallets and other products are used by Pfizer. However, the company said it banned the use of TBP-treated pallets for their boots, and the producers of the U.S. platform has also banned the use of TBP.
However, the FDA said that, the Doha Development Agenda, delivered in the wood products to present the U.S. from other countries.
Pfizer has begun the withdrawal in August but not publicly until October, when he announced expanded the recall of further batches. The company said that the company that supplies the bottles changed their methods to resolve the problem in August, but held the lot affected by this latest recall before that date.
"The filling in its bottles by the supplier before the changes can be made on the market, it is possible that further reminds necessary," Pfizer said.
musty odors reports as massive recall of paracetamol Johnson & Johnson brand products, which followed in 2009, Tylenol, which had additional memories of other drugs that provoked similar complaints began.
Another drug recall
The odor problem Tylenol, now under criminal investigation by the FDA has finally announced a reorganization of the administration of Johnson & Johnson.Pfizer the CEO unexpectedly earlier this month that resulted in his resignation but have reminded Lipitor was not raised as a reason.
The recall relates to a new batch of 19,000 additional unlimited bottles of 40 mg Lipitor, which brings the total number of bottles from the shelves to 360,000.
In a statement, Pfizer attributed to the musty smell of a chemical called 2,4,6-tribromoanisole (TBA), in a bottle of Lipitor were what one of the largest consumer complaints.The FDA identified noted that the health effects of low have taken concentrations of TBA is minimal, especially gastrointestinal upset consumers, the products affected by the aromatic compound.
TBA is actually from another chemical, TED, as a preservative in wood shipping pallets and other products are used by Pfizer. However, the company said it banned the use of TBP-treated pallets for their boots, and the producers of the U.S. platform has also banned the use of TBP.
However, the FDA said that, the Doha Development Agenda, delivered in the wood products to present the U.S. from other countries.
Pfizer has begun the withdrawal in August but not publicly until October, when he announced expanded the recall of further batches. The company said that the company that supplies the bottles changed their methods to resolve the problem in August, but held the lot affected by this latest recall before that date.
"The filling in its bottles by the supplier before the changes can be made on the market, it is possible that further reminds necessary," Pfizer said.
musty odors reports as massive recall of paracetamol Johnson & Johnson brand products, which followed in 2009, Tylenol, which had additional memories of other drugs that provoked similar complaints began.
Another drug recall
The odor problem Tylenol, now under criminal investigation by the FDA has finally announced a reorganization of the administration of Johnson & Johnson.Pfizer the CEO unexpectedly earlier this month that resulted in his resignation but have reminded Lipitor was not raised as a reason.
